| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,181 |
11,829 |
$2.72M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,218 |
924 |
$1.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,007 |
4,855 |
$1000K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,390 |
2,676 |
$807K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,833 |
1,260 |
$468K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,643 |
1,485 |
$409K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,520 |
4,594 |
$260K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,023 |
1,369 |
$218K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,841 |
3,643 |
$216K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,001 |
2,075 |
$177K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,696 |
1,600 |
$176K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,028 |
1,672 |
$174K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,380 |
1,761 |
$158K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
194 |
156 |
$145K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,281 |
2,310 |
$143K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,247 |
1,768 |
$131K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,979 |
1,951 |
$128K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,534 |
4,218 |
$121K |
| 71045 |
Radiologic examination, chest; single view |
2,996 |
2,079 |
$109K |
| 71046 |
Radiologic examination, chest; 2 views |
1,830 |
1,379 |
$105K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
102 |
86 |
$89K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
254 |
175 |
$82K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,162 |
3,098 |
$71K |
| 80053 |
Comprehensive metabolic panel |
12,051 |
8,882 |
$66K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,488 |
11,456 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,910 |
2,254 |
$56K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,555 |
858 |
$48K |
| 73630 |
|
571 |
419 |
$45K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,079 |
1,726 |
$34K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
447 |
342 |
$33K |
| 73130 |
|
308 |
232 |
$32K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,245 |
2,930 |
$31K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,169 |
802 |
$31K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
161 |
130 |
$31K |
| 73610 |
|
307 |
219 |
$29K |
| 96376 |
|
637 |
363 |
$26K |
| 97162 |
|
317 |
247 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,598 |
2,126 |
$23K |
| 80061 |
Lipid panel |
1,973 |
1,696 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,295 |
1,930 |
$19K |
| 84484 |
|
5,348 |
2,774 |
$19K |
| 73562 |
|
194 |
141 |
$18K |
| 73110 |
|
178 |
132 |
$18K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
311 |
192 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,153 |
2,785 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,043 |
405 |
$15K |
| 80306 |
|
2,006 |
1,415 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
618 |
530 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
602 |
516 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
537 |
443 |
$11K |
| 87070 |
|
1,844 |
1,496 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,462 |
858 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
552 |
448 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
328 |
228 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,488 |
1,821 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,997 |
1,531 |
$8K |
| 83690 |
|
2,234 |
1,675 |
$8K |
| 73030 |
|
105 |
63 |
$8K |
| 99215 |
Prolong outpt/office vis |
566 |
254 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
141 |
60 |
$7K |
| 87077 |
|
1,405 |
904 |
$6K |
| 84703 |
|
1,218 |
917 |
$6K |
| 97161 |
|
63 |
55 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,012 |
732 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
146 |
115 |
$6K |
| 81001 |
|
3,744 |
2,693 |
$5K |
| 87040 |
|
1,448 |
535 |
$5K |
| 81025 |
|
1,254 |
1,016 |
$5K |
| 71250 |
|
14 |
13 |
$5K |
| 87186 |
|
1,087 |
722 |
$5K |
| 83880 |
|
460 |
291 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,556 |
1,117 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
177 |
155 |
$4K |
| 83735 |
|
1,645 |
1,018 |
$4K |
| 83605 |
|
998 |
574 |
$3K |
| 82077 |
|
326 |
227 |
$3K |
| 85379 |
|
559 |
430 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
63 |
13 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
9,925 |
7,377 |
$3K |
| 80143 |
|
292 |
204 |
$3K |
| 94375 |
|
30 |
25 |
$3K |
| 80179 |
|
266 |
197 |
$3K |
| 87807 |
|
258 |
225 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,811 |
1,257 |
$3K |
| 84439 |
|
356 |
307 |
$2K |
| 74018 |
|
22 |
12 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
295 |
225 |
$2K |
| 81003 |
|
2,198 |
1,674 |
$2K |
| 80076 |
|
338 |
268 |
$2K |
| 90715 |
|
58 |
38 |
$2K |
| 85610 |
|
917 |
553 |
$2K |
| 82607 |
|
194 |
164 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
322 |
171 |
$2K |
| 72100 |
|
13 |
12 |
$1K |
| 86140 |
|
397 |
301 |
$1K |
| 76376 |
|
19 |
13 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
166 |
124 |
$1K |
| 87147 |
|
212 |
139 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
69 |
45 |
$1K |
| 81002 |
|
668 |
496 |
$1K |
| 96367 |
|
17 |
13 |
$981.47 |
| 86803 |
|
89 |
79 |
$968.17 |
| 97535 |
Self-care/home management training, each 15 minutes |
34 |
27 |
$952.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
106 |
81 |
$872.42 |
| J2060 |
Injection, lorazepam, 2 mg |
488 |
292 |
$845.49 |
| 99442 |
|
47 |
26 |
$844.15 |
| 36416 |
|
459 |
313 |
$813.37 |
| 85027 |
|
199 |
147 |
$636.48 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
105 |
57 |
$541.15 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
14 |
$535.51 |
| 81015 |
|
373 |
237 |
$467.00 |
| 80050 |
General health panel |
54 |
50 |
$391.37 |
| 82803 |
|
35 |
25 |
$357.75 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
27 |
12 |
$347.97 |
| 82728 |
|
34 |
31 |
$301.93 |
| 83655 |
|
29 |
27 |
$297.08 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$296.16 |
| G0008 |
Administration of influenza virus vaccine |
260 |
161 |
$264.99 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
117 |
76 |
$248.81 |
| 90686 |
|
203 |
132 |
$223.92 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
52 |
28 |
$219.02 |
| 82248 |
|
44 |
32 |
$184.83 |
| 85652 |
|
94 |
78 |
$169.87 |
| 83550 |
|
38 |
26 |
$144.31 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
70 |
49 |
$138.06 |
| 83540 |
|
38 |
26 |
$107.01 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
64 |
41 |
$83.89 |
| 90653 |
|
44 |
28 |
$78.93 |
| 87205 |
|
28 |
24 |
$72.86 |
| 82150 |
|
16 |
14 |
$60.93 |
| 85730 |
|
20 |
13 |
$46.89 |
| 87210 |
|
14 |
14 |
$37.28 |
| 85014 |
|
14 |
13 |
$25.96 |
| 85018 |
|
14 |
13 |
$25.96 |
| 90662 |
|
17 |
14 |
$17.60 |
| A9270 |
Non-covered item or service |
434 |
116 |
$0.00 |